Latest Stock Split Details
Key information about XTL Biopharmaceuticals Ltd.'s most recent stock split
Split Date: 2026-03-25
Split Ratio: 1:4
Price Before Split: $0.68
Price After Split: $0.17
Developer API
Get XTLB split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/XTLB
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 4.00 times fewer shares (a 1:4 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of XTL Biopharmaceuticals Ltd.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-03-25 | 1:4 | Yes | $0.68 | $0.17 |
| 2025-12-24 | 1:4 | Yes | $0.20 | $0.05 |
| 2017-02-10 | 1:5 | Yes | $0.15 | $0.03 |
| 2012-10-04 | 1:10 | Yes | $0.17 | $0.02 |
About XTL Biopharmaceuticals Ltd.
Company overview and industry information
XTL Biopharmaceuticals Ltd. (XTLB) operates in the Biotechnology industry. The recent 1-for-4 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to XTL Biopharmaceuticals Ltd. Summary